Table 4.
MACE (major adverse cardiac event) | N | Total MACE | Rate |
---|---|---|---|
Cardiac death | 3 | 5 | 3.16 |
Myocardial infarction | 0 | ||
TVR | 2 |
Stent thrombosis | Acute | Sub-acute | Late | Very late |
---|---|---|---|---|
Definite | 2 | 0 | 0 | |
Probable | 0 | 1 | 0 | 0 |
Possible | 0 | 0 | 0 | 0 |
*Major Adverse Cardiac Events (MACE) within the study population, defined as composite of cardiac death, myocardial infarction (Q-wave and non-Q-wave), or justified target vessel revascularization at 12 months.